Mirae Asset Global Etfs Holdings Ltd. Ionis Pharmaceuticals Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 9,450 shares of IONS stock, worth $317,992. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,450
Previous 7,825
20.77%
Holding current value
$317,992
Previous $313,000
5.43%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IONS
# of Institutions
396Shares Held
132MCall Options Held
752KPut Options Held
741K-
Vanguard Group Inc Valley Forge, PA16.4MShares$551 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$477 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$386 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$347 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$265 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.78B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...